ArticleBMC oral health2026
Spatially resolved proteomics provides insights into the normal-dysplasia-tumor continuum in oral squamous cell carcinoma.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundOral epithelial dysplasia is a recognized precursor lesion for oral squamous cell carcinoma (OSCC), yet the proteomic changes underlying the progression from normal epithelium to dysplasia and ultimately to OSCC remain incompletely characterized. This gap is partially due to the high interpatient heterogeneity of OSCC, the frequent reliance on cross-patient comparisons, and the omission of dysplasia as a critical intermediate stage.
methodsA histology-guided, spatially resolved proteomics workflow was applied to formalin-fixed paraffin-embedded tissue blocks from six patients with primary OSCC. For each case, spatially contiguous normal (N), dysplasia (D), and tumor (T) regions from the same lesion-bearing block, yielding 18 regional proteomes. Proteins were profiled using data-independent acquisition liquid chromatography-tandem mass spectrometry. Downstream analyses included differential expression analysis, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment, soft-clustering trajectory analysis, protein-protein interaction analysis, exploratory clinicopathological stratification, and immunohistochemistry validation.
resultsThe spatially matched N-D-T dataset identified 1,683 proteins in N, 2,100 in D, and 1,966 in T. Under the predefined differential-expression threshold, the N vs. D comparison yielded more differentially expressed proteins than the D vs. T comparison, suggesting that threshold-detectable proteomic alterations may already be present at dysplasia. Functionally, the N-to-D transition was associated with cell-cycle activation, proliferative signaling, hypoxia-associated responses, and metabolic alterations, whereas the D-to-T transition was more closely related to cytoskeletal organization, motor activity, and structural remodeling. Across the overall N-to-T contrast, glycolysis, pyruvate metabolism, and broader metabolic reprogramming predominated. Trajectory analysis resolved Early Warning, Progression, and dysplasia-restricted transient modules, suggesting a non-linear architecture of proteomic evolution during OSCC progression. MYO1B showed progression-associated spatial increase from N to D and T regions, whereas HSP90AB1 was prioritized as a candidate invasion-associated hub supported by proteomic, protein-protein interaction network, and external transcriptomic analyses.
conclusionsSpatially resolved proteomics of archived formalin-fixed paraffin-embedded tissues provides a morphology-anchored proteomic continuum of oral malignant transformation in a small spatially matched cohort. The data suggest that OSCC progression involves early-shift, progressive, and transient dysplasia-specific programs. These findings offer candidate proteins and biological hypotheses for further validation in larger oral cancer cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.